Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes

被引：1

作者：

Wägner, AM

Ordóñez-Llanos, J

Jorba, O

Pérez, A

机构：

[1] Hosp Sant Pau, Dept Endocrinol, Barcelona 08025, Spain

[2] Hosp Sant Pau, Dept Metab & Biochem, Barcelona 08025, Spain

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 2004年 / 53卷 / 11期

关键词：

D O I：

10.1016/j.metabol.2004.07.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1516 / 1516

页数：1

共 4 条

[1] LDL PARTICLE-SIZE DISTRIBUTION - RESULTS FROM THE FRAMINGHAM OFFSPRING STUDY [J].

CAMPOS, H ;

BLIJLEVENS, E ;

MCNAMARA, JR ;

ORDOVAS, JM ;

POSNER, BM ;

WILSON, PWF ;

CASTELLI, WP ;

SCHAEFER, EJ .

ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (12) :1410-1419

[2]

ORTOLA J, 1992, CLIN CHEM, V38, P56

[3] Efficacy of atorvastatin and gemfibrozil, alone and in low dose combination, in the treatment of diabetic dyslipidemia [J].

Wägner, AM ;

Jorba, O ;

Bonet, R ;

Ordóñez-Llanos, J ;

Pérez, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3212-3217

[4] LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes [J].

Wägner, AM ;

Jorba, O ;

Rigla, M ;

Alonso, E ;

Ordóñez-Llanos, J ;

Pérez, A .

ACTA DIABETOLOGICA, 2002, 39 (04) :215-220

← 1 →